Blood Journal

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  

Blood Journal
Jan 12, 2025, 06:45 | Insight
Richard Buka: TPO-RA - Sustained Responses in ITP After Stopping Treatment
Richard Buka, Chair of HaemSTAR, shared a post on X about a paper by Adrien…
Jan 10, 2025, 19:51 | Insight
Uma Borate: Reducing Clinical Trial Eligibility Barriers for MDS
Uma Borate, Acute Leukemia Clinical Section Head and Research Director at James Cancer Hospital shared…
Jan 7, 2025, 12:06 | Science
Rahul Banerjee: Joseph Mikhael's commentary about our SWOG dexamethasone analysis
Rahul Banerjee, Assistant professor at Fred Hutchinson Cancer Center at the University of Washington, shared…
Jan 4, 2025, 13:13 | Insight
Amer Zeidan: Reducing Clinical Trial Eligibility Barriers for Myelodysplastic Syndromes/Neoplasms
Amer Zeidan, Associate Professor of Medicine (Hematology) at Yale University, shared a post on X,…
Jan 3, 2025, 16:17 | Science
Iannis Aifantis: Our short review/discussion of the Comazzetto and Morrison Ascorbate deficiency
Iannis Aifantis, Chairman of the Department of Pathology at NYU School of Medicine, shared a…
Dec 27, 2024, 15:31 | Science
Akshay Sharma: How I treat Sickle Cell Disease with Gene Therapy
Akshay Sharma, Instructor in the Department of Bone Marrow Transplantation and Cellular Therapy, shared a…
Dec 15, 2024, 10:14 | Insight
Ciara Freeman: How soluble BCMA quantification and MTV from SOC PET can predict tumor burden
Ciara Freeman, Assistant Member, Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer…
Dec 10, 2024, 14:00 | Blog
Naveen Pemmaraju: State-of-the-art review of BPDCN
Naveen Pemmaraju, Professor and Director of BPDCN Program at the Department of Leukemia at the…
Nov 22, 2024, 11:03 | Insight
Myeloma Paper of the Day, November 22nd, suggested by Robert Orlowski
Robert Orlowski shared a post on X: “Myeloma Paper of the Day: Hyperdiploidy (HD) happens after somatic…
Nov 6, 2024, 16:47 | Insight
Curtis Lachowiez: Refining risk prediction for HMA and venetoclax-based treatment in AML
Curtis Lachowiez, Assistant Professor of Medicine at Oregon Health and Science University, shared a post…
Nov 3, 2024, 14:02 | Blog
Risk stratification/scoring in MPNs
Anand Patel, Assistant Professor and Director of the Inpatient Leukemia Service at the University of…
Nov 2, 2024, 17:34 | Insight
Venetoclax and Pegcrisantaspase for Relapsed or Refractory Acute Myeloid Leukemia
Anand Patel, Assistant Professor and Director of the Inpatient Leukemia Service at the University of…
Oct 25, 2024, 12:25 | Insight
Myeloma Paper of the Day, October 25th, suggested by Robert Orlowski
Robert Orlowski shared on X: “Paper of the Day: Soluble B-cell maturation antigen levels may be useful…
Oct 13, 2024, 15:04 | Blog
Mulham Ombada: Difficult Case of a Severe Refractory ITP
Mulham Ombada, Internal Medicine Residency at Upstate Medical University, shared a post on X: "Excited to…
Oct 11, 2024, 17:33 | Insight
Naveen Pemmaraju: Blastic Plasmacytoid Dendritic Cell Neoplasm treatment with focus on SCT
Naveen Pemmaraju shared a post about a recent paper titled "How I treat Blastic Plasmacytoid…
Oct 9, 2024, 16:24 | Insight
Jonathan Licht: How KDM6A controls MHC-I and II expression in multiple myeloma cells
Jonathan Licht, Director of the UF Health Cancer Center, shared a post on X: "Our…
Oct 4, 2024, 15:20 | Insight
Rahul Banerjee: Dexamethasone 40mg weekly in Multiple Myeloma induction
Rahul Banerjee shared his recent article on X: "Grateful to Blood Journal, co-authors, and SWOG…
Sep 8, 2024, 08:29 | Blog
Talha Badar: Cerebrospinal fluid distribution and pharmacokinetics of ponatinib in Ph1+ ALL
Talha Badar shared a post on X, about recent paper published in Blood Neoplasia: Cerebrospinal…
Aug 31, 2024, 10:03 | Insight
Myeloma Paper of the Day, August 31st, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Updated KarMMa-3 analyses shows Ide-cel…
Aug 30, 2024, 10:57 | Insight
Myeloma Paper of the Day, August 30th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: International retrospective cohort study to…
Aug 25, 2024, 09:29 | Insight
Rahul Banerjee: Fascinating Multiple Myeloma results of MajesTEC-1 in BCMA-exposed patients
Rahul Banerjee shared a post by Robert Z. Orlowski, Director of Myeloma Section at MD Anderson…
Aug 19, 2024, 10:38 | Insight
Hagop Kantarjian: All you need to know about the latest JAK inhibitor to be approved for myelofibrosis
Hagop Kantarjian shared a post on X about a recent paper by Prithviraj Bose published…
Aug 19, 2024, 10:29 | Insight
New ELN classification of AML receiving less intense therapies
Eddie Cliff, Haematology Registrar at Peter MacCallum Cancer Centre, shared a post on X about…
Aug 10, 2024, 12:42 | Blog
Rahul Banerjee: MajesTEC-1 analysis of response predictors in Multiple Myeloma by Cortes-Selva
Rahul Banerjee, Assistant Professor at University of Washington, shared a post on X:  "EXCELLENT Blood…
Jul 28, 2024, 12:28 | Insight
Ross Firestone: Antigen escape with BCMA-targeting therapies in multiple myeloma
Ross Firestone, Hematology/Oncology Fellow at Memorial Sloan Kettering Cancer Center, shared a post on X…
Jul 15, 2024, 21:23 | Insight
Herculean effort on risk prediction model for clonal cytopenias
UChicago Leukemia Program shared a post on X about a recent paper by Zhuoer Xie et…
Jul 14, 2024, 22:08 | Blog
Rahul Banerjee: IL-18: magnifying glass, rejuvenating cream, and phone-a-friend all in one for T cells
Rahul Banerjee, Assistant Professor at UW Medicine, shared a post on X: ''Fascinating MMsm work…
Jul 8, 2024, 01:07 | Blog
Konstantinos Kokkaliaris: Niche-centric strategies to revert aging and chemotherapy-related hematopoietic decline
Konstantinos Kokkaliaris, Junior group leader at Dr. Senckenberg Institute of Pathology, shared a post on…
Jul 1, 2024, 14:22 | Insight
Ponatinib CSF concentrations in Ph+ ALL
Anand Patel shared on X: "Very informative paper in Blood Journal looking at ponatinib CSF concentrations…
Jun 30, 2024, 13:19 | Blog
Apply now to organize a Poster Walk for ASH24
ASH shared a post on X: “Apply now to organize a Poster Walk for ASH24!…
May 25, 2024, 12:44 | Blog
Emma M. Groarke: Excited to see our collaboration looking at VTE in VEXAS syndrome out in this issue of Blood Journal!
Emma M. Groarke, Hematologist at the National Institutes of Health (NIH), shared a post on…
May 24, 2024, 01:21 | Insight
Recent FDA Committee Vote Could Speed Multiple Myeloma Drug Approval
Sylvester-led analysis on minimal residual disease as clinical endpoint guided committee decision A U.S. Food…
Mar 25, 2024, 05:56 | Insight
Carmelo Gurnari: Overexcited for this achievement shedding new insights into PNH clinico-biological features
Carmelo Gurnari, Hematologist/Oncologist and Researcher at Cleveland Clinic, posted on X: "Overexcited for this achievement…
Mar 17, 2024, 13:43 | Insight
Samer Al Hadidi: How to counsel patients about Cilta Cel
Samer Al Hadidi, Assistant Professor at UAMS Myeloma Center, made the following post on X/Twitter:…
Feb 8, 2024, 14:58 | Blog
Emma M. Groarke: We found that there was more than 40% cumulative incidence of venous and arterial thrombosis in patients with VEXAS
Emma M. Groarke, Hematologist at the National Institutes of Health (NIH), shared a post on…
Nov 28, 2023, 23:04 | Insight
Juan P. Alderuccio: Our approach to secondary CNS involvement by aggressive lymphomas
Juan P. Alderuccio, Lymphoma Physician at Sylvester Comprehensive Cancer Center, made the following post on…
Nov 13, 2023, 13:43 | Drugs
Jayastu Senapati: Check out the commentary to our paper in the Blood Journal by Paresh Vyas
Jayastu Senapati, Leukemia fellow at MD Anderson Cancer Centre, shared on X/Twitter: "Check out the…
Nov 7, 2023, 18:03 | Insight
Lachelle Dawn: Excited to share our review article in Blood Journal on the Causes and Consequences of Clonal Hematopoiesis
Lachelle Dawn, Hematologist and Scientist at Dana-Farber Cancer Institute, shared on Twitter: "Excited to share…
All: 38 Posts: 1 - 100
Special Coverage